Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Polychronakos

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|December 16, 1987
Specificity of insulin-like growth factor binding to type-II IGF receptors in rabbit mammary gland and hypophysectomized rat liverB Barenton, H J Guyda, C G Goodyer, et al.
Diabetes Care|June 1, 1988
Impact of SMBG on control of diabetes as measured by HbA1. 3-yr survey of a juvenile IDDM clinicM M Belmonte, A Schiffrin, J Dufresne, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1982
The role of cell age in the difference in insulin binding between adult and cord erythrocytesC Polychronakos, M D Ruggere, A Benjamin, et al.
Genes and Immunity|December 4, 2009
Remapping the type I diabetes association of the CTLA4 locusH-Q Qu, J P Bradfield, S F A Grant, et al.
Hormone Research|January 1, 1981
Perinatal activity of the hypothalamic-pituitary-gonadal axis in the lamb. III. LH, testosterone and prolactin secretory pattern in newborn lambsS Savoie, C Polychronakos, M G Forest, et al.
Clinical and Experimental Immunology|November 19, 2013
Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locusH Zouk, E D'Hennezel, X Du, et al.
Journal of Autoimmunity|June 1, 1996
Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytesP Vafiadis, S T Bennett, E Colle, et al.
Anticancer Research|March 1, 1993
Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastasesM Koutsilieris, G Frenette, C Lazure, et al.
Cancer Research|July 1, 1996
Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomasA Sourla, C Polychronakos, W R Zeng, et al.
Diabetes|August 1, 1985
Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changesR Burstein, C Polychronakos, C J Toews, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|December 16, 1987
Specificity of insulin-like growth factor binding to type-II IGF receptors in rabbit mammary gland and hypophysectomized rat liverB Barenton, H J Guyda, C G Goodyer, et al.
Diabetes Care|June 1, 1988
Impact of SMBG on control of diabetes as measured by HbA1. 3-yr survey of a juvenile IDDM clinicM M Belmonte, A Schiffrin, J Dufresne, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1982
The role of cell age in the difference in insulin binding between adult and cord erythrocytesC Polychronakos, M D Ruggere, A Benjamin, et al.
Genes and Immunity|December 4, 2009
Remapping the type I diabetes association of the CTLA4 locusH-Q Qu, J P Bradfield, S F A Grant, et al.
Hormone Research|January 1, 1981
Perinatal activity of the hypothalamic-pituitary-gonadal axis in the lamb. III. LH, testosterone and prolactin secretory pattern in newborn lambsS Savoie, C Polychronakos, M G Forest, et al.
Clinical and Experimental Immunology|November 19, 2013
Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locusH Zouk, E D'Hennezel, X Du, et al.
Journal of Autoimmunity|June 1, 1996
Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytesP Vafiadis, S T Bennett, E Colle, et al.
Anticancer Research|March 1, 1993
Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastasesM Koutsilieris, G Frenette, C Lazure, et al.
Cancer Research|July 1, 1996
Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomasA Sourla, C Polychronakos, W R Zeng, et al.
Diabetes|August 1, 1985
Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changesR Burstein, C Polychronakos, C J Toews, et al.
Pageof 9